Please be aware of a change to the prior authorization requirement announced in April for home health services.

As of July 1, 2022, Hodgkin lymphoma and renal cell carcinoma will be added to our Cancer Therapy Pathways Program.

Medical policy updates for July 2022 for the following plans: Medicare, Medicaid, Exchanges, and Commercial.

Antipsychotic medications prescribed for child or adolescent patients can have adverse effects on their metabolism. We’ve listed suggested considerations for monitoring and follow-up care, and compiled a list of helpful UnitedHealthcare resources.

You may be caring for a UnitedHealthcare Commercial member who has been prescribed antidepressant medication. We’ll be encouraging these members to keep their scheduled appointments and work with you to create a treatment plan.